Beth C. Seidenberg, Director at Vera Therapeutics, Inc. (VERA), bought 178,594 shares at $7.12 ($1.3M) on 2023-03-17, disclosed to the SEC on 2023-03-21.
Open-market purchase of $1.3M VERA by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $7.12 | 74,045 | $527K | 41.4% |
| 2 | $7.12 | 74,045 | $527K | 41.4% |
| 3 | $7.21 | 15,252 | $110K | 8.6% |
| 4 | $7.21 | 15,252 | $110K | 8.6% |
| Total | $7.14 avg | 178,594 | $1.3M | 100% |
| Filing → |
| VERA | SELL | 2024-09-20 | $1.3M | — | Filing → |
| SGMT | BUY | 2023-07-20 | $750K | — | Filing → |
| SLRN | BUY | 2023-05-11 | $23.6M | — | Filing → |